Feedback / Questions
FCARH143 - BMS, Fred Hutchinson Cancer Center, National Cancer Institute
https://www.targetedonc.com/view/novel-car-t-cell-therapy-fcarh143-delivers-high-responses-and-survival-in-relapsed-refractory-multiple-myeloma
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next